Recent News

• 02.05.2026 - A New Era For Psychedelic Therapeutics [Drug Discovery News]
• 01.29.2026 - Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
• 01.28.2026 - Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
• 01.28.2026 - Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Recent Filings

• 02.04.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.02.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.28.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 01.28.2026 - 8-K Current report
• 01.28.2026 - EX-99.1 EX-99.1
• 01.09.2026 - 8-K Current report
• 01.09.2026 - EX-99.1 EX-99.1
• 01.05.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 12.31.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 12.30.2025 - 4 Statement of changes in beneficial ownership of securities